ACC/AHA Classification of Care Metrics: Performance Measures and Quality Metrics

TY - JOUR

T1 - ACC/AHA Classification of Care Metrics

T2 - Performance Measures and Quality Metrics

AU - Bonow, Robert O.

AU - Masoudi, Frederick A.

AU - Rumsfeld, John S.

AU - DeLong, Elizabeth

AU - Estes, N. A Mark

AU - Goff, David C.

AU - Grady, Kathleen

AU - Green, Lee A.

AU - Loth, Ann R.

AU - Peterson, Eric D.

AU - Piña, Ileana L.

AU - Radford, Martha J.

AU - Shahian, David M.

N1 - Funding Information: American College of Cardiology Foundation John C. Lewin, MD, Chief Executive Officer Charlene May, Senior Director, Science and Clinical Policy Melanie Shahriary, RN, BSN, Associate Director, Performance Measures and Data Standards Erin A. Barrett, Senior Specialist, Science and Clinical Policy American Heart Association M. Cass Wheeler, Chief Executive Officer Rose Marie Robertson, MD, FACC, FAHA, Chief Science Officer Gayle R. Whitman, PhD, RN, FAHA, FAAN, Senior Vice President, Office of Science Operations Anne Leonard, RN, MPH, Science and Medicine Advisor Appendix A Author Relationships With Industry and Other Entities: ACC/AHA Classification of Care Metrics: Performance Measures and Quality Metrics Name Research Grant Speakers' Bureau/Honoraria/Expert Witness Stock Ownership/Equity Interests Consultant/Advisory Board/Steering Committee Robert O. Bonow None None None Edwards Lifesciences Elizabeth DeLong None None None None N.A. Mark Estes III None Boston Scientific None None Medtronic St. Jude Medical David C. Goff, Jr None None None None Kathleen Grady None None None None Lee A. Green None None None None Ann R. Loth None None None None Frederick A. Masoudi Amgen ⁎ Amgen None None Takeda UnitedHealth Eric D. Peterson Bristol Myers-Squibb/Sanofi-Aventis ⁎ Genentech None None Corgentech CV Therapeutics Merck ⁎ Schering Plough ⁎ Ileana L. Piña None AstraZeneca None None GlaxoSmithKline Novartis Martha J. Radford None None None None John S. Rumsfeld None St. Jude Medical None Northfield Labs United Healthcare David M. Shahian None None None None This table represents the relationships of committee members with industry and other entities that were reported by the authors as relevant to this topic during the document development process. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity or ownership of $10 000 or more of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. ACC indicates American College of Cardiology; and AHA, American Heart Association. ⁎ Significant (greater than $10 000) relationship. Appendix B Peer Reviewer Relationships With Industry and Other Entities: ACC/AHA Classification of Care Metrics: Performance Measures and Quality Metrics Name Representation Research Grant Speakers' Bureau/Honoraria/Expert Witness Stock Ownership/Equity Interests Consultant/Advisory Board/Steering Committee Nancy M. Albert Official Reviewer—AHA–Get With the Guidelines Program None None None None Gregg C. Fonarow Official Reviewer—AHA–Get With the Guidelines Program GlaxoSmithKline ⁎ AstraZeneca ⁎ None None Medtronic ⁎ GlaxoSmithKline ⁎ Pfizer ⁎ Medtronic ⁎ Merck-Schering Plough ⁎ Pfizer ⁎ Eric Smith Official Reviewer—AHA–Get With the Guidelines Program None None None None Stuart Winston Official Reviewer—ACCF Board of Governors Boston Scientific Boston Scientific None None Medtronic Ralph Brindis Content Reviewer—ACCF-NCDR Management Board None None None None Gregory Dehmer Content Reviewer—ACCF-NCDR Management Board None None None None James T. Dove Content Reviewer—ACCF-NCDR Management Board None None None None Charles R. McKay Content Reviewer—ACCF-NCDR Management Board None None None None W. Douglas Weaver Content Reviewer—ACCF-NCDR Management Board Procter & Gamble None Accorn Cardiovascular American Heart Association—Detroit Affiliate Board of Trustees Schering Plough William Weintraub Content Reviewer—ACCF-NCDR Management Board None None None None This table represents the relationships of peer reviewers with industry and other entities that were reported as relevant to this topic during the document development process. It does not necessarily reflect relationships at the time of publication. Names are listed in alphabetical order within each category of review. Participation in the peer review process does not imply endorsement of this document. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, ownership of $10 000 or more of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. ACC indicates American College of Cardiology; AHA, American Heart Association; and NCDR, National Cardiovascular Data Registry. ⁎ Significant (greater than $10 000) relationship.

PY - 2008/12/9

Y1 - 2008/12/9

KW - ACC/AHA Performance Measures

KW - performance measurement

KW - quality metrics

UR - http://www.scopus.com/inward/record.url?scp=56849098153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56849098153&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2008.10.014

DO - 10.1016/j.jacc.2008.10.014

M3 - Review article

C2 - 19056002

AN - SCOPUS:56849098153

SN - 0735-1097

VL - 52

SP - 2113

EP - 2117

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 24

ER -